» Authors » Enrico Agabiti Rosei

Enrico Agabiti Rosei

Explore the profile of Enrico Agabiti Rosei including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 132
Citations 8785
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Agabiti-Rosei C, Saxton S, De Ciuceis C, Muiesan M, Rizzoni D, Agabiti Rosei E, et al.
Hypertension . 2023 Nov; 81(1):24-33. PMID: 37937425
Alterations in microcirculation play a crucial role in the pathogenesis of cardiovascular and metabolic disorders such as obesity and hypertension. The small resistance arteries of these patients show a typical...
2.
De Ciuceis C, Agabiti Rosei C, Malerba P, Rossini C, Nardin M, Chiarini G, et al.
Eur J Intern Med . 2023 Nov; 122:86-92. PMID: 37914655
Objective: Microvascular structural alterations may be considered an important form of hypertension-mediated organ damage. An increased media-to-lumen ratio of subcutaneous small arteries evaluated with locally invasive techniques (micromyography) predicts the...
3.
Maloberti A, Mengozzi A, Russo E, Cicero A, Angeli F, Agabiti Rosei E, et al.
High Blood Press Cardiovasc Prev . 2023 Oct; 30(5):411-425. PMID: 37792253
The relationship between Serum Uric Acid (UA) and Cardiovascular (CV) diseases has already been extensively evaluated, and it was found to be an independent predictor of all-cause and cardiovascular mortality...
4.
Del Pinto R, Desideri G, Ferri C, Agabiti Rosei E
High Blood Press Cardiovasc Prev . 2021 Jun; 28(5):457-466. PMID: 34185255
Introduction: Achieving hypertension control is beneficial regardless of age. Fixed-combination pills have the potential of increasing adherence to treatment, improving the benefit/risk ratio, and simplifying therapy, with resulting convenience especially...
5.
Kasiakogias A, Agabiti Rosei E, Camafort M, Ehret G, Faconti L, Ferreira J, et al.
J Hypertens . 2021 Jun; 39(8):1522-1545. PMID: 34102660
Hypertension constitutes a major risk factor for heart failure with preserved ejection fraction (HFpEF). HFpEF is a prevalent clinical syndrome with increased cardiovascular morbidity and mortality. Specific guideline-directed medical therapy...
6.
Agabiti Rosei E, Muiesan M, Salvetti M, Paini A, Agabiti Rosei C, Aggiusti C, et al.
Panminerva Med . 2021 May; 63(4):458-463. PMID: 33988330
The Vobarno Study represents the first observational study aimed to assess in a general population sample the relationship between parameters of cardiac and vascular structure (and function) and blood pressure...
7.
Muiesan M, Agabiti Rosei E, Borghi C, De Luca N, Ghiadoni L, Grassi G, et al.
High Blood Press Cardiovasc Prev . 2021 Feb; 28(2):151-157. PMID: 33544372
The approach to hypertensive emergiencies (HE) and urgencies (HU) may be different according to local clinical practice, despite recent guidelines and position papers recommendations. The Italian Society of Hypertension (Società...
8.
Maloberti A, Bombelli M, Facchetti R, Barbagallo C, Bernardino B, Agabiti Rosei E, et al.
J Hypertens . 2020 Nov; 39(2):333-340. PMID: 33239553
Objective: Although the relationship between hyperuricemia and cardiovascular events has been extensively examined, data on the role of diuretic-related hyperuricemia are still scanty. The present study was designed to collect...
9.
Savoia C, De Ciuceis C, Paini A, Carletti R, Arrabito E, Nicoletti C, et al.
J Hypertens . 2020 Aug; 39(1):169-180. PMID: 32740409
Objective: We tested the hypothesis that chronic treatment with the direct renin inhibitor aliskiren improves vascular function in resistance and conduit arteries of type two diabetic and hypertensive patients. Method:...
10.
Agabiti Rosei E, Chiarini G, Rizzoni D
Eur Heart J Suppl . 2020 Jun; 22(Suppl E):E1-E6. PMID: 32523429
Arterial blood pressure (BP) is a continuous variable, with a physiology characterized by significant variability stemming from the complex interaction among haemodynamic factors, neuronal reflexes, as well as hormonal, behavioural,...